Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 33Observational 4

Sponsor

Cancer Type

Genitourinary 3NET 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 92Neoplasms 87Lung Neoplasms 55Prostatic Neoplasms 48Colorectal Neoplasms 42Carcinoma, Non-Small-Cell Lung 35Pancreatic Neoplasms 24Multiple Myeloma 24Stomach Neoplasms 21Hematologic Neoplasms 21Carcinoma, Hepatocellular 19Ovarian Neoplasms 18Melanoma 17Lymphoma 16Leukemia, Myeloid, Acute 16Esophageal Neoplasms 16Brain Neoplasms 16Urinary Bladder Neoplasms 13Liver Neoplasms 13Colonic Neoplasms 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 12Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Kidney Neoplasms 12Head and Neck Neoplasms 12Endometrial Neoplasms 12Disease 12Recurrence 11

Interventions

Transurethral Resection of Prostate 1Radiofrequency Ablation 1Positron-Emission Tomography 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Adenocarcinoma × 30 days × Clear all
NCT00923026 2026-05-22

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
1,150 enrolled
DermatologicEndocrineNET

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT06807398 2026-05-15

RF-2018-123683

IRCCS San Raffaele

Completed
367 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06862856 2026-05-15

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Massachusetts General Hospital

Recruiting
50 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Withdrawn
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡